Skip to main content

Advertisement

Table 2 The Number and Severity of Adverse Events Experienced by the Subjects during the Study (only those events with ≥ 5% frequency are shown).

From: A randomized controlled trial of a novel mixed monoamine reuptake inhibitor in adults with ADHD

   NS2359 Placebo
Body System Symptom Mild Mod Severe Mild Mod Severe
Gastrointestinal Disorders Diarrhea NOS 4 1 0 0 0 0
  Dry Mouth 5 3 0 7 0 0
  Dyspepsia 6 0 0 3 1 0
  Nausea 4 1 0 6 0 1
General disorders and administration site conditions Fatigue 1 2 0 7 0 0
Infections & Infestations Nasopharyngitis 3 1 0 4 0 1
  Upper Respiratory Tract infection 6 1 0 5 2 0
Investigations Weight decrease 5 1 0 0 0 0
Metabolism and nutrition disorders Appetite decreased NOS 5 1 0 6 0 0
Musculoskeletal and Connective Tissue Disorders Back Pain 1 1 0 5 1 0
Nervous system Disorders Dizziness 5 2 0 3 0 0
  Headache NOS 15 6 1 15 5 1
  Irregular Sleep Phases 3 0 1 2 0 0
  Somnolence 0 0 0 4 1 0
Psychiatric disorders Initial Insomnia 1 3 0 2 0 0
  Insomnia 8 3 1 2 0 1
  Irritability 5 1 0 0 2 0
  Middle Insomnia 7 0 0 1 0 0